Search

Your search keyword '"Bedrosian I"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Bedrosian I" Remove constraint Author: "Bedrosian I"
327 results on '"Bedrosian I"'

Search Results

1. Contralateral prophylactic mastectomy: current perspectives

2. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

14. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients

15. Using NCDB for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer

16. Abstract P2-11-12: Prospective comparison of late toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multi-lumen intracavitary brachytherapy

21. Abstract P2-01-05: A phase II clinical trial of VST-1001 (dilute fluorescein) in lymphatic mapping and sentinel lymph node localization in clinically node negative breast cancer

23. Abstract P3-01-09: A phase I clinical trial of VST-1001 (dilute fluorescein) in lymphatic mapping and sentinel lymph node localization in clinically node negative breast cancer

24. Abstract P5-14-07: Comparison of infectious complications between breast conserving therapy with catheter-based accelerated partial irradiation and whole breast irradiation

26. Abstract P1-07-06: Effect of biospecimen variables on proteomic biomarker assessment in breast cancer

27. Abstract P1-07-09: Estrogen receptor positivity: 10% or 1%?

34. Impact of chemotherapy timing on local-regional failures in patients with breast cancer undergoing breast-conserving therapy.

40. Abstract PD06-08: Size Matters: Incorporation of Sentinel Lymph Node (SLN) Metastasis Size into a Nomogram Predicting NonSLN Involvement in SLN Positive Breast Cancer Patients

42. Correlation of single nucleotide polymorphisms (SNPs) of hypoxia-related genes with pathologic complete response (pCR) following neoadjuvant chemoradiation (chemoXRT) for locally advanced rectal cancer.

44. Eradication of Axillary Lymph Node Metastases Occurs in 74% of Patients Receiving Neoadjuvant Chemotherapy with Concurrent Trastuzumab for HER2 Positive Breast Cancer.

Catalog

Books, media, physical & digital resources